ClinicalTrials.gg
Not yet recruitingNCT07522190Updated Nov 5, 2026

Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism

An interventional study of Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT) in Autism Spectrum Disorder (ASD) and Autism, sponsored by Stanford University. Not yet recruiting at 1 site in United States. Open to participants aged 2 Years to 4 Years. Per ClinicalTrials.gov, last updated 2026-11-05.

Primary conditionAutistic DisorderRegistry: Autism Spectrum DisorderReclassifiedWhy we changed it
Registry
Autism Spectrum Disorder — the first condition term the registry derived for this study.
ClinicalTrials.gg
Autistic Disorder
Why
  1. The study's listed conditions name Autistic Disorder, a narrower term within Autism Spectrum Disorder.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
2 Years to 4 Years
Sex
All
01

Study summary

The goal of this study is to compare two well-established early autism interventions, Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT), to better understand which approach is most effective for improving communication skills in young children with autism and which children may benefit most from each treatment. Additionally, after completing either the ESDM or PRT, some participants who meet specific clinical criteria may be offered home-based Developmental Reciprocity Treatment (DRT). The study will include boys and girls 2 to 4 years 11 months old diagnosed with ASD. The main questions this study aims to answer are whether center-based ESDM and center-based PRT improve communication skills in young children with autism, and whether certain children respond better to one treatment approach than the other. Participants will be randomly assigned to either ESDM or PRT for 24 weeks in a center-based program, attend treatment session 4 days per week (\~3 hours/day), complete developmental and autism assessments at baseline, 12 weeks, and 24 weeks, have a parent participate in weekly parent training sessions, and complete follow-up assessments at weeks 36 and 48.

02

Conditions studied

  • Autism Spectrum Disorder (ASD)
  • Autism

Browse trials for

Keywords

  • Autism
  • Autism Spectrum Disorder
  • Early Start Denver Model (ESDM)
  • Pivotal Response Treatment (PRT)
  • Early Intervention
  • Naturalistic Developmental Behavioral Intervention (NDBI)
  • Communication
  • Early Development
  • Parents
  • Language
03

In context

Autistic Disorder Reclassified

1,030 studies on the registry are indexed under Autistic Disorder; 266 are open to participants now.

This study's planned enrollment of 140 is above the median of 49 across 811 interventional studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

Stanford University is the lead sponsor of 2,168 studies on the registry; 431 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.

Compared within Autistic Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Autism Spectrum Disorder. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
2 Years to 4 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children must be between 2 and 4 years, 11 months of age at enrollment
  • Confirmed diagnosis of autism spectrum disorder based on standardized diagnostic assessments and clinical judgment
  • Demonstrated significant language delay as determined by standardized language measures
  • Ability to participate in study assessments and intervention procedures
  • At least one English-speaking parent or caregiver available to participate in parent training and research measures
  • Receiving stable community-based treatments or medications for at least one month prior to baseline, with no anticipated changes during the study period

Exclusion criteria

Exclusion Criteria:

  • Current or lifetime diagnosis of a severe psychiatric disorder (e.g., bipolar disorder)
  • Presence of an active or unstable medical condition (e.g., uncontrolled seizure disorder or significant cardiac disease)
  • Child's primary language is not English
  • Prior adequate trial of PRT or ESDM
  • Receipt of more than 15 hours per week of in-home applied behavior analysis services
  • Inability to complete study assessments or procedures to obtain valid data
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Early Start Denver Model (ESDM)

    Behavioral: Early Start Denver Model (ESDM)

  • Experimental
    Pivotal Response Treatment (PRT)

    Behavioral: Pivotal Response Treatment (PRT)

  • Experimental
    Developmental Reciprocity Treatment (DRT)

    Behavioral: Developmental Reciprocity Treatment (DRT)

Interventions

  • BehavioralEarly Start Denver Model (ESDM)

    ESDM is a comprehensive, play-based early intervention that integrates applied behavior analysis with developmental and social-pragmatic approaches. ESDM uses a structured curriculum to systematically target communication, social engagement, imitation, cognition, and play skills. The intervention is delivered within joint activity routines that emphasize the interactions between the child and adult. Goals are individualized and embedded into naturalistic play and daily routines to support developmental progress. Children will participate in center-based treatment 4 days per week for 3 hours per day for 24 weeks. The parent will be encouraged to practice the intervention at home and submit one 10-minute parent-child interaction video regularly during the 24 weeks.

  • BehavioralPivotal Response Treatment (PRT)

    PRT s a naturalistic, play-based intervention based on principles of applied behavior analysis. Instead of working on developing skills in isolation, PRT focuses on "pivotal" areas of development like motivation, responsivity to cues, and self-initiation. The idea is that working on these areas will lead to broad improvements across communication and behavior. Through the intervention, therapists and parents integrate various strategies into child-led play to increase communication and engagement. Children will participate in center-based treatment 4 days per week for 3 hours per day for 24 weeks. The parent will be encouraged to practice the intervention at home and submit one 10-minute parent-child interaction video regularly during the 24 weeks.

  • BehavioralDevelopmental Reciprocity Treatment (DRT)

    DRT is a relationship-based, developmental intervention that targets the foundations of social reciprocity such as shared attention, emotional engagement, and back-and-forth interaction. DRT emphasizes building the child's capacity for mutual engagement with parents or therapists through interactions that follow the child's lead. This will be a 24-week home-based intervention for with weekly parent training

06

What researchers measure

Primary outcomes

  1. Week 24 Clinical Global Impressions - Improvement (CGI-I)

    A clinician rating that measures how much a child's overall symptoms and functioning have improved or worsened compared to the start of treatment. The CGI ratings will be assessed by a psychologist blind to group assignment and treatment phase, and will specifically focus on social and communication skills.

    Time frame: Baseline, Week 12, Week 24, Week 36, Week 48

Secondary outcomes

  1. Change from Baseline on Functional utterances during Structured Laboratory Observation (SLO)

    The number of meaningful spoken words or phrases a child uses to communicate during a structured play interaction with the parent.

    Time frame: Baseline, Week 12, Week 24, Week 36, Week 48

  2. Change from Baseline on Early Start Denver Model Curriculum Checklist (ESDM-CC)

    A clinician-rated assessment used to measure a child's developmental skills across multiple areas, including communication, social interaction, play, and cognitive abilities. Scores reflect skills gained across developmental domains over time.

    Time frame: Baseline, Week 12, Week 24, Week 36, Week 48

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jan 2037, 120 months later.

Of 354 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 52. This study's planned 120 months is above that.

Counting every sponsor, half of 366 studies reached it within 26 months; a quarter within 13 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2026
First posted
Apr 13, 2026
StartEst.
Jan 2027
Primary completionEst.
Jan 2037
CompletionEst.
Jan 2037
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07522190
Collaborators
John and Marcia Goldman Foundation
Responsible party
Antonio Hardan (Professor of Psychiatry & Behavioral Sciences, Stanford University) — Principal investigator
First posted
Apr 13, 2026
Start date
Jan 2027 (estimated)
Primary completion
Jan 2037 (estimated)
Completion
Jan 2037 (estimated)
Last update
Nov 5, 2026

Study contacts

Juliya Pattammady, PhD
Contact
PALprogram@stanford.edu
650-736-1235
Robin Libove
Contact
rlibove@stanford.edu
650-736-1235
Antonio Hardan, MD
principal investigator · Stanford University
Grace Gengoux, PhD
principal investigator · Stanford University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion